Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review von Xin, Lei, Gao, Jinfang, Zheng, Ziliang, Chen, Yiyou, Lv, Shuxin, Zhao, Zhikai, Yu, Chunhai, Yang, Xiaotang, Zhang, Ruiping

Volltext

Rapid screening for individualized chemotherapy optimization of colorectal cancer: A novel conditional reprogramming technology-based functional diagnostic assay von Li, Yingjie, Guo, Dagang, Zhang, Yihong, Wang, Lin, Sun, Tingting, Li, Zhongwu, Zhang, Xiaoyan, Wang, Shuai, Chen, Yiyou, Wu, Aiwen

Volltext

P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN‐LABEL, PHASE 2 STUDY OF PC‐002(SEPB)，A FIRST‐IN‐CLASS INHIBITOR OF DEUBIQUITINASES TARGETI... von Yoon, Sung‐Soo, LI, Zhiming, Zhou, Keshu, Zhou, Xiaoxi, Guo, Ye, Zhang, Huilai, Eom, Ki‐Seong, Jin Kim, Seok, Yong Oh, Sung, Lim, Sungnam, Youssoufian, Hagop, Jiang, Vernon C, Huang, Zanchun, Kilfoil, Georgina, Wang, Xin, Cao, Zhixiang, LI, Xiang, Wu, Alexander, Chen, Yiyou, Song, Yuqin

Volltext

Linear-depth quantum circuits for loading Fourier approximations of arbitrary functions von Moosa, Mudassir, Watts, Thomas W, Chen, Yiyou, Sarma, Abhijat, McMahon, Peter L

Volltext

Combined Proteomic and Metabolomic Analysis of the Molecular Mechanism Underlying the Response to Salt Stress during Seed Germination in Barley von Chen, Yiyou, Wang, Juncheng, Yao, Lirong, Li, Baochun, Ma, Xiaole, Si, Erjing, Yang, Ke, Li, Chengdao, Shang, Xunwu, Meng, Yaxiong, Wang, Huajun

Volltext

Decoherence mitigation by embedding a logical qubit in a qudit von Miyahara, Hideyuki, Chen, Yiyou, Roychowdhury, Vwani, Bouchard, Louis-Serge

Volltext

YM155 inhibits neuroblastoma growth through degradation of MYCN: A new role as a USP7 inhibitor von Li, Xiang, Yang, Feili, He, Na, Zhang, Ming, Lv, Yan, Yu, Yue, Dong, Qian, Hou, Xiaofu, Hao, Yanbing, An, Zhida, Zhang, Haiwen, Yang, Zhen, Zhai, Heiyan, Guo, Dagang, Cao, Zhixiang, Jiang, Vernon C., Chen, Yiyou

Volltext

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy von Zhang, Lianhai, Yang, Jie, Cai, Jie, Song, Xiaoming, Deng, Jianyun, Huang, Xuesong, Chen, Dawei, Yang, Mengmeng, Wery, Jean-Pierre, Li, Shuangxi, Wu, Aiwen, Li, Ziyu, Li, Zhongwu, Liu, Yiqiang, Chen, Yiyou, Li, Qixiang, Ji, Jiafu

Volltext

Treatment of Relapsed/Refractory Hgbcl and Bukitt's Lymphoma with c-Myc Rearrangement: A Multi-Center, Open-Label, Phase 2 Study of PC-002 (SepB), a First-in-Class Deubiquitinase I... von Yoon, Sung-Soo, Li, Zhiming, Zhou, Keshu, Zhou, Xiaoxi, Guo, Ye, Zhang, Huilai, Eom, Ki-Seong, Kim, Seok Jin, Oh, Sung Yong, Lim, Sung-Nam, Youssoufian, Hagop, Jiang, Vernon, Huang, Zhanchun, Kilfoil, Georgina, Wang, Xin, Cao, Zhixiang, LI, Xiang, Lin, Yihai, Wu, Alexander, Chen, Yiyou, Song, Yuqin

Volltext

Quantum approximation of normalized Schatten norms and applications to learning von Chen, Yiyou, Miyahara, Hideyuki, Bouchard, Louis-S., Roychowdhury, Vwani

Volltext

Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients von Yang, Mengmeng, Shan, Baoen, Li, Qiaoxia, Song, Xiaoming, Cai, Jie, Deng, Jianyun, Zhang, Likun, Du, Zhenjian, Lu, Junjie, Chen, Taiping, Wery, Jean‐Pierre, Chen, Yiyou, Li, Qixiang

Volltext

Conditionally reprogrammed colorectal cancer cells combined with mouse avatars identify synergy between EGFR and MEK or CDK4/6 inhibitors von Wang, Yanni, Liao, Haiyan, Zheng, Tongsen, Wang, Jingyuan, Guo, Dagang, Lu, Zhihao, Li, Zhongwu, Chen, Yiyou, Shen, Lin, Zhang, Yanqiao, Gao, Jing

Volltext

Use of RAS pathway activation or KRAS mutation status to predict cetuximab response in CRC patient-derived xenografts von Li, Henry, Chen, Dawei, Guo, Sheng, Cai, Jie, Chen, Yiyou, Wery, Jean-Pierre

Volltext

Abstract 1322: Autocrine c-met/HGF HCC patient derived xenograft (PDX) models for evaluating c-met inhibitors von Chen, Dawei, Song, Xiaoming, Cai, Jie, Chen, Taiping, Chen, Yiyou, Li, Henry Q.X.

Volltext

Abstract 4170: Primary Orthotopic Hepatocellular Carcinoma Models for Evaluation of Anticancer Drugs von Chen, Dawei, Chen, Taiping, Wery, Jean-Pierre, Chen, Yiyou

Volltext

Abstract 2784: Growth of patient derived tumor xenograft (PDX) in NOD/SCID mice reconstituted with human umbilical cord blood (UCB) CD34+ cells von An, Xiaoyu (Annie), Yang, Mengmeng, Wu, Ran, Liu, Jinping, Chen, Taiping, Wery, Jean-Pierre, Chen, Yiyou, Li, Henry

Volltext

Abstract 5630: Treatments of NSCLC-PDX with c-MET gene amplification by c-MET inhibitors lead to rapid development of drug resistance von Yang, Mengmeng, Song, Xiaoming, Cai, JIe, Wang, Youzhu, Chen, Taiping, Wery, Jean-Pierre, Chen, Yiyou, Li, Henry

Volltext

Abstract 2344: PDX from the naïve NSCLC patients containing activating EGFR mutations are resistant to erlotinib but sensitive to c-met inhibitor von Yang, Mengmeng, Deng, Jiangyun, Song, Xiaoming, Cai, Jie, Chen, Taiping, Chen, Yiyou, Li, Henry Q.X.

Volltext

Abstract C113: Modeling cetuximab clinical trial by conducting in vivo efficacy evaluation in large panel CRC patient-derived xenograft (PDX) models von Chen, Dawei, Yang, Mengmeng, Deng, Jiangyun, Song, Xiaoming, Cai, Jie, Chen, Taiping, Chen, Yiyou, Li, Henry

Volltext

Abstract 2731: Classification of HCC patient derived xenograft (PDX) models by transcriptome and microRNome profiling, and their resemblance to patients von Guo, Sheng, Qian, Wubin, Cai, Jie, Chen, Dawei, Yang, Jie, Wang, Zhun, Song, Xiaoming, Chen, Taiping, Wery, Jean Pierre, Chen, Yiyou, Li, Henry QX

Volltext